Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials

AIM: We assessed the efficacy and safety of 5-hydroxytryptamine (5-HT(3)) receptor antagonists in adults with non-constipated irritable bowel syndrome (IBS) or diarrhea-predominant IBS (IBS-D). METHODS: We searched PubMed, MEDLINE, EMBASE, and the Cochrane Controlled Trials Register for randomized c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yongping, Yu, Ting, Tang, Yurong, Xiong, Wenjie, Shen, Xiaoxue, Jiang, Ling, Lin, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349445/
https://www.ncbi.nlm.nih.gov/pubmed/28291778
http://dx.doi.org/10.1371/journal.pone.0172846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349445/
https://www.ncbi.nlm.nih.gov/pubmed/28291778
http://dx.doi.org/10.1371/journal.pone.0172846

Ejemplares similares